<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although growing evidence demonstrates that TWIST1 is an interesting <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biomarker, little is known about the clinical significance of TWIST1 expression and TWIST1 methylation in human primary <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we examined the association of TWIST1 expression and TWIST1 methylation with clinicopathologic features in human primary <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Primary <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) specimens from 319 patients, corresponding <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal nontumorous mucosa from 251 patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, and colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> from 189 patients were used </plain></SENT>
<SENT sid="3" pm="."><plain>Methylation and expression levels of TWIST1 were compared with clinicopathologic features </plain></SENT>
<SENT sid="4" pm="."><plain>The TWIST1 methylation level was higher in colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> than in <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal mucosa </plain></SENT>
<SENT sid="5" pm="."><plain>Elevated TWIST1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal mucosa in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> as well as in primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> specimens was associated with unfavorable outcomes </plain></SENT>
<SENT sid="6" pm="."><plain>There was no correlation between TWIST1 methylation and TWIST1 expression </plain></SENT>
<SENT sid="7" pm="."><plain>Our results suggest that TWIST1 methylation may be a useful biomarker for screening <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, TWIST1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression is a possible molecular marker for predicting the outcome in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Confirmatory studies using independent data sets are needed to confirm our findings </plain></SENT>
</text></document>